Both in Pharmaceuticals
Arcutis Biotherapeutics vs Definium Therapeutics
Over the past year ARQT returned +26.4% and DFTX returned +111.1%; their daily moves had a correlation of 0.30.
ARQT +26.4% DFTX +111.1%Growth of $1, one year, split-adjusted
| Metric | ARQT | DFTX |
|---|---|---|
| Price | $33.32 | $32.47 |
| Market cap | $4.19B | $4.36B |
| Today | +4.11% | −2.81% |
| 1 month | +39.3% | −8.8% |
| 6 months | +37.8% | +38.6% |
| Year to date | +14.7% | — |
| 1 year | +34.6% | — |
| Revenue growth (YoY) | +59.3% | — |
| Gross margin | 91.6% | — |
| Net margin | 11.6% | — |
| P/E (TTM) | 146.8× | — |
| Price / sales | 9.0× | — |
| Net cash | $129.7M | $1.05B |
| Dividend yield | — | — |
| Volatility (60d) | 54.0% | 57.0% |
| Short % of float | 18.0% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).